These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28609734)

  • 1. Assessment of treatment patterns and healthcare costs associated with probable Lennox-Gastaut syndrome.
    Piña-Garza JE; Montouris GD; Vekeman F; Cheng WY; Tuttle E; Giguere-Duval P; Duh MS; Shen V; Saurer TB; Isojarvi J
    Epilepsy Behav; 2017 Aug; 73():46-50. PubMed ID: 28609734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
    Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
    Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of illness in Lennox-Gastaut syndrome: a systematic literature review.
    Strzelczyk A; Zuberi SM; Striano P; Rosenow F; Schubert-Bast S
    Orphanet J Rare Dis; 2023 Mar; 18(1):42. PubMed ID: 36859290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a classifier to identify patients with probable Lennox-Gastaut syndrome in health insurance claims databases via random forest methodology.
    Vekeman F; Piña-Garza JE; Cheng WY; Tuttle E; Giguère-Duval P; Oganisian A; Damron J; Sheng Duh M; Shen V; Saurer TB; Montouris GD; Isojarvi J
    Curr Med Res Opin; 2019 Aug; 35(8):1415-1420. PubMed ID: 30870597
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology, healthcare resource use, and mortality in patients with probable Lennox-Gastaut syndrome: A population-based study on German health insurance data.
    Strzelczyk A; Schubert-Bast S; Simon A; Wyatt G; Holland R; Rosenow F
    Epilepsy Behav; 2021 Feb; 115():107647. PubMed ID: 33358132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, healthcare resource utilization and mortality of Lennox-Gastaut syndrome: retrospective linkage cohort study.
    Chin RFM; Pickrell WO; Guelfucci F; Martin M; Holland R
    Seizure; 2021 Oct; 91():159-166. PubMed ID: 34161904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review.
    Samanta D
    Epilepsy Behav; 2021 Jan; 114(Pt A):107612. PubMed ID: 33243685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome.
    François C; Stern JM; Ogbonnaya A; Lokhandwala T; Landsman-Blumberg P; Duhig A; Shen V; Tan R
    J Mark Access Health Policy; 2017; 5(1):1318691. PubMed ID: 28740620
    [No Abstract]   [Full Text] [Related]  

  • 9. Lennox-Gastaut syndrome: a comprehensive review.
    Asadi-Pooya AA
    Neurol Sci; 2018 Mar; 39(3):403-414. PubMed ID: 29124439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Diagnosis and Treatment of Lennox-Gastaut Syndrome.
    Resnick T; Sheth RD
    J Child Neurol; 2017 Oct; 32(11):947-955. PubMed ID: 28689466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric Slow-Spike-Wave Patterns with Maximal Discharges Contralateral to MRI Lesions Predict Better Surgical Prognosis in Symptomatic Lennox-Gastaut Syndrome or Lennox-Gastaut Phenotypes.
    Yang MH; Liu J; Zhou YL; Yang H; Cai FC; Zempel J; Yang QW; Liu SY
    Pediatr Neurosurg; 2020; 55(1):26-35. PubMed ID: 31851997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK.
    Benedict A; Verdian L; Maclaine G
    Pharmacoeconomics; 2010; 28(3):185-99. PubMed ID: 20151724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Few individuals with Lennox-Gastaut syndrome have autism spectrum disorder: a comparison with Dravet syndrome.
    He N; Li BM; Li ZX; Wang J; Liu XR; Meng H; Tang B; Bian WJ; Shi YW; Liao WP
    J Neurodev Disord; 2018 Mar; 10(1):10. PubMed ID: 29558884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budget impact analysis of antiepileptic drugs for Lennox-Gastaut syndrome.
    Skornicki M; Clements KM; O'Sullivan AK
    J Manag Care Spec Pharm; 2014 Apr; 20(4):400-6. PubMed ID: 24684645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expert opinion: Proposed diagnostic and treatment algorithms for Lennox-Gastaut syndrome in adult patients.
    Montouris G; Aboumatar S; Burdette D; Kothare S; Kuzniecky R; Rosenfeld W; Chung S
    Epilepsy Behav; 2020 Sep; 110():107146. PubMed ID: 32563898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study.
    Nikanorova M; Brandt C; Auvin S; McMurray R
    Epilepsy Behav; 2017 Nov; 76():63-70. PubMed ID: 28927712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying the ILAE diagnostic criteria for Lennox-Gastaut syndrome in the real-world setting: A multicenter retrospective cohort study.
    Nightscales R; Chen Z; Barnard S; Auvrez C; Tao G; Sivathamboo S; Bennett C; Rychkova M; D'Souza W; Berkovic SF; Nicolo JP; O'Brien TJ; Perucca P; Scheffer IE; Kwan P
    Epilepsia Open; 2024 Apr; 9(2):602-612. PubMed ID: 38135919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognosis of patients with Lennox--Gastaut syndrome in recent decades.
    Kim HJ; Kim HD; Lee JS; Heo K; Kim DS; Kang HC
    Epilepsy Res; 2015 Feb; 110():10-9. PubMed ID: 25616450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world use of the updated refractory epilepsy screening tool for Lennox-Gastaut syndrome.
    Wolf SM; Boyce D; Peña P; Piña-Garza JE; Roland JJ; Thomas B; Zogejani D; McGoldrick PE
    Epilepsia Open; 2024 Aug; 9(4):1277-1286. PubMed ID: 38726917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing considerations for rufinamide in patients with Lennox-Gastaut syndrome: Phase III trial results and real-world clinical data.
    Kothare S; Kluger G; Sachdeo R; Williams B; Olhaye O; Perdomo C; Bibbiani F
    Seizure; 2017 Apr; 47():25-33. PubMed ID: 28284045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.